PERSPECTIVE THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $1.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-16
- PERSPECTIVE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $1.19M, a 29.63% decline from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $1.68M, a 453.95% increase from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $304.00K.
- PERSPECTIVE THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $126.00K, a 162.50% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|---|
| 2025-12-31 | $1.19M 10-K · filed 2026-03-16 | |
| 2024-12-31 | $1.68M 10-K · filed 2026-03-16 | |
| 2023-12-31 | $304.00K 10-K/A · filed 2025-03-28 | |
| 2022-12-31 | $70.00K 10-K · filed 2024-03-28 | |
| 2022-06-30 | $126.00K 10-K · filed 2024-03-28 | |
| 2021-06-30 | $48.00K 10-KT · filed 2023-05-01 | |
| 2020-06-30 | $0.00 10-KT · filed 2023-05-01 | |
| 2019-06-30 | $0.00 10-K · filed 2021-09-27 | |
| 2017-06-30 | $10.00K 10-K · filed 2019-09-27 | |
| 2016-06-30 | $0.00 10-K · filed 2017-09-28 | |
| 2015-06-30 | $0.00 10-K · filed 2017-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |